MYO.AMEXMyomo, INC

4/A: Myomo CEO Paul Gudonis Receives 130,000 Restricted Stock Units

Sentiment:

SEC Form 4/A Filing


Myomo CEO Paul Gudonis was granted 130,000 restricted stock units, which vest over three years starting June 5, 2025, according to a recent SEC filing.

Summary

  • Paul R. Gudonis, CEO of Myomo, Inc., received 130,000 restricted stock units on June 5, 2024.
  • These restricted stock units were granted under the company's 2018 Stock Option and Incentive Plan.
  • Each unit represents a contingent right to receive one share of Myomo's common stock.
  • The units will vest in annual installments over three years, beginning on June 5, 2025.
  • Following this transaction, Gudonis beneficially owns 1,008,245 shares of Myomo common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications, but it is not a major positive event either.

Positives

  • The grant of restricted stock units aligns the CEO's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the CEO.

Risks

  • The vesting of the restricted stock units could potentially dilute existing shareholders if new shares are issued.

Industry Context

This type of equity grant is a common practice for incentivizing and retaining key executives in publicly traded companies, particularly in the technology and medical device sectors.

Comparison to Industry Standards

  • Equity grants are a standard component of executive compensation packages in the medical device industry.
  • Companies like Insulet and Intuitive Surgical also use stock options and restricted stock units to align executive interests with shareholder value.
  • The vesting schedule of three years is typical for such grants, ensuring long-term commitment from the executive.

Stakeholder Impact

  • Shareholders may view this as a positive sign of management's commitment to the company's long-term success.
  • Employees may see this as a sign of stability and confidence in the company's leadership.

Key Dates

DateDescription
06/05/2024Date of the restricted stock unit grant to Paul Gudonis.
06/07/2024Original filing date of the Form 4, which was later amended.
01/22/2025Date of signature on the amended filing.
06/05/2025Start date for the annual vesting of the restricted stock units.

Keywords

restricted stock units, stock options, executive compensation, insider trading, beneficial ownership, Myomo, MYO, Paul Gudonis

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.